Gene · 3860
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Update on S100A16 in Human Cancer. | Biomolecules | 2023 | 37509106 | PubTator, text mining | PubMed |
| Full thickness 3D in vitro conjunctiva model enables goblet cell differentiation. | Sci Rep | 2023 | 37507439 | PubTator, text mining | PubMed |
| Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour. | Microbiome | 2023 | 37496039 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria. | J Antimicrob Chemother | 2023 | 37473441 | PubTator, text mining | PubMed |
| Maxillary neoplasms in four dromedary camels. | Front Vet Sci | 2023 | 37456952 | PubTator, text mining | PubMed |
| Molecular Characterization of Esophageal Squamous Cell Carcinoma Using Quantitative Proteomics. | Cancers (Basel) | 2023 | 37444412 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing: Opportunities and Challenges for Studies on Corneal Biology in Health and Disease. | Cells | 2023 | 37443842 | PubTator, text mining | PubMed |
| CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes. | J Exp Clin Cancer Res | 2023 | 37443031 | PubTator, text mining | PubMed |
| Predator-Prey Interactions between Halobacteriovorax and Pathogenic Vibrio parahaemolyticus Strains: Geographical Considerations and Influence of Vibrio Hemolysins. | Microbiol Spectr | 2023 | 37409976 | PubTator, text mining | PubMed |
| Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases. | Front Immunol | 2023 | 37409125 | PubTator, text mining | PubMed |
| Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections. | Respir Res | 2023 | 37407993 | PubTator, text mining | PubMed |
| Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. | Front Oncol | 2023 | 37397364 | PubTator, text mining | PubMed |
| Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome. | Nat Commun | 2023 | 37391405 | PubTator, text mining | PubMed |
| Introducing a new type of alternative laryngeal mucosa model. | PLoS One | 2023 | 37390090 | PubTator, text mining | PubMed |
| Identification of BST2 as a conjunctival epithelial stem/progenitor cell marker. | iScience | 2023 | 37389178 | PubTator, text mining | PubMed |
| HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation. | PLoS Pathog | 2023 | 37379354 | PubTator, text mining | PubMed |
Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of Plasmodium falciparum dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon. | Pathogens | 2023 | 37375534 | PubTator, text mining | PubMed |
| Systematic analysis of the molecular and biophysical properties of key DNA damage response factors. | Elife | 2023 | 37341699 | PubTator, text mining | PubMed |
| Therapeutic efficacy of pyronaridine-artesunate (Pyramax®) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia. | Malar J | 2023 | 37330475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3860/papers?page=12